Pemivibart Biosimilar - Research Grade

Human

Severe acute respiratory syndrome coronavirus 2

5mg/ml

IgG1 - lambda2

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Blue ice

Neutralization of the SARS-CoV-2 spike protein continues to anchor antiviral and immunology research. This recombinant human IgG1 (lambda) antibody is an unconjugated, non-therapeutic analog of pemivibart, expressed in CHO cells against severe acute respiratory syndrome coronavirus 2. For research use only, it is purified to a low-endotoxin standard suitable for in vivo work and manufactured in scalable milligram (mg) to gram (g) quantities for high-throughput, heavy-usage laboratories. It functions as a defined comparator and active reagent in neutralization assays, functional studies, epitope characterization, and preclinical coronavirus models. Reliable batch-to-batch consistency suits laboratories running extended experimental campaigns.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks